Authors
Loading...
Research shows improved biosafety and immune response in gene therapy using a novel AAV vector, suggesting potential advantages over traditional methods.
Caihong Gao (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: